Clinical Trials Browser

Interventional × zipalertinib × 30 days × Clear all

NCT07128199 2026-04-07

REZILIENT4

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05967689 2026-04-03

REZILIENT2

Phase 2 Recruiting

Carcinoma, Lung Diseases